Fraxiparine 3075IU Injection
Marketer
Glaxo SmithKline Pharmaceuticals Ltd
Salt Composition
Nadroparin (3075IU)
Overview Fraxiparine 3075IU Injection
Nadroparin Calcium 3075 IU Injection is an anticoagulant medication preventing and treating dangerous blood clots. It inhibits clot growth and formation in vital areas like the legs, lungs, brain, and heart. Administration is solely by a healthcare professional (doctor or nurse). Dosage and treatment duration depend on individual factors such as your health status, treatment goals, response to therapy, age, and weight. Continued injections are crucial, even without symptoms, for ongoing clot prevention. Discontinuing treatment risks clot formation. Potential side effects include bleeding, injection site reactions, elevated liver enzymes, and hematomas at the injection site. Minimize activities increasing bleeding risk; exercise caution with sharp objects. Prior to use, disclose conditions like hypertension, diabetes, or recent stroke history to your physician. This medication is contraindicated with active bleeding. Inform your doctor of all other medications to ensure safe concurrent use. Pregnant or breastfeeding individuals should consult their physician before using Nadroparin Calcium 3075 IU Injection.
Primary Ingredients of Fraxiparine 3075IU Injection
The provided text is "undefined," which offers no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Fraxiparine 3075IU Injection
Managing and averting blood clot formation.
Major Benefits of Fraxiparine 3075IU Injection:
The medication will be administered by your physician or their qualified assistant; self-medication is strongly discouraged.
Common Side effects of Fraxiparine 3075IU Injection:
- Injection site reaction
- Bleeding
- Injection site hematoma
- Increased liver enzymes
How to use Fraxiparine 3075IU Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Fraxiparine 3075IU Injection works:
The injectable anticoagulant, Fraxiparine 3075 IU, inhibits the development of potentially dangerous blood clots.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Fraxiparine 3075IU Injection may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Fraxiparine 3075 IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Administering Fraxiparine 3075 IU Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability following Fraxiparine 3075IU Injection administration is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Nadroparin calcium 3075 IU injection requires careful administration in individuals with advanced renal impairment. Dosage modification of nadroparin calcium 3075 IU injection may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Fraxiparine 3075IU Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Fraxiparine 3075IU Injection :
Should you forget a scheduled dose of Fraxiparine 3075 IU Injection, seek medical advice.
Facts to Know About Fraxiparine 3075IU Injection
| Label | Value |
|---|---|
| Chemical Category | Low-molecular-weight heparin |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | Low-molecular-weight heparin (LMWH) |
3,018 People bought this recently